Mechanisms of multidrug resistance in cancer chemotherapy

K Bukowski, M Kciuk, R Kontek - International journal of molecular …, 2020 - mdpi.com
Cancer is one of the main causes of death worldwide. Despite the significant development of
methods of cancer healing during the past decades, chemotherapy still remains the main …

DNA repair pathways and cisplatin resistance: an intimate relationship

CRR Rocha, MM Silva, A Quinet, JB Cabral-Neto… - Clinics, 2018 - SciELO Brasil
The main goal of chemotherapeutic drugs is to induce massive cell death in tumors.
Cisplatin is an antitumor drug widely used to treat several types of cancer. Despite its …

[HTML][HTML] ATM and ATR as therapeutic targets in cancer

AM Weber, AJ Ryan - Pharmacology & therapeutics, 2015 - Elsevier
In order to maintain genomic stability, cells have developed sophisticated signalling
pathways to enable DNA damage or DNA replication stress to be resolved. Key mediators of …

[HTML][HTML] Not breathing is not an option: How to deal with oxidative DNA damage

E Markkanen - DNA repair, 2017 - Elsevier
Oxidative DNA damage constitutes a major threat to genetic integrity, and has thus been
implicated in the pathogenesis of a wide variety of diseases, including cancer and …

Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation

W Topatana, S Juengpanich, S Li, J Cao, J Hu… - Journal of hematology & …, 2020 - Springer
Synthetic lethality is a lethal phenomenon in which the occurrence of a single genetic event
is tolerable for cell survival, whereas the co-occurrence of multiple genetic events results in …

Targeting the replication stress response through synthetic lethal strategies in cancer medicine

NYL Ngoi, MM Pham, DSP Tan, TA Yap - Trends in cancer, 2021 - cell.com
The replication stress response (RSR) involves a downstream kinase cascade comprising
ataxia telangiectasia-mutated (ATM), ATM and rad3-related (ATR), checkpoint kinases 1 and …

Antitumor drugs and their targets

Z Dembic - Molecules, 2020 - mdpi.com
Through novel methodologies, including both basic and clinical research, progress has
been made in the therapy of solid cancer. Recent innovations in anticancer therapies …

Synthetically lethal interactions of ATM, ATR, and DNA-PKcs

OL Kantidze, AK Velichko, AV Luzhin, NV Petrova… - Trends in cancer, 2018 - cell.com
Synthetic lethality occurs when simultaneous perturbations of two genes or molecular
processes result in a loss of cell viability. The number of known synthetically lethal …

Targeting DNA-PK in cancer

G Damia - … Research/Fundamental and Molecular Mechanisms of …, 2020 - Elsevier
DNA-dependent protein kinase (DNA-PK) is involved in many cellular pathways. It has a key
role in the cellular response to DNA damage, in the repair of DNA double-strand break (DNA …

[HTML][HTML] ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious …

J Aguilar-Company, M Fernández-Ruiz… - Clinical Microbiology …, 2018 - Elsevier
Background The present review is part of the European Society of Clinical Microbiology and
Infectious Diseases (ESCMID) Study Group for Infections in Compromised Hosts (ESGICH) …